PACIRA BIOSCIENCES, INC. (PCRX) Capital expenditures 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$15.3MFY2025 · since FY2016: $24.7M → $15.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.3M | +44.2% |
| FY2024 | $10.6M | -29.8% |
| FY2023 | $15.2M | -49.6% |
| FY2022 | $30.1M | -34.4% |
| FY2021 | $45.9M | +21.3% |
| FY2020 | $37.8M | +272.1% |
| FY2019 | $10.2M | -30.0% |
| FY2018 | $14.5M | -24.7% |
| FY2017 | $19.3M | -22.0% |
| FY2016 | $24.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice